← Back
$VTGN All transactions

Vistagen Therapeutics, Inc.

A

$ Value

$0

Shares

150,000

Price

$0

Filed

Jun 25

Insider

Name

Cote Elissa S.

Title

Chief Corp Development Officer

CIK

0002069951

Roles

Officer

Transaction Details

Transaction Date

2025-06-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

150,000

Footnotes

25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. | The stock options were granted in connection with the Reporting Person's appointment as Chief Corporate Development Officer.

Filing Info

Accession No.

0001415889-25-018206

Form Type

4

Issuer CIK

0001411685

Cote Elissa S.'s History

Date Ticker Type Value
2026-04-07 VTGN A $0
2025-06-23 VTGN A $0

Other Insiders at VTGN (90d)

Insider Bought Sold Last
Singh Shawn
President and CEO
2026-04-07
Tressler Nick B.
Chief Financial Officer
2026-04-07
Adler Reid G.
Chief Legal Officer
2026-04-07
Prince Joshua S.
Chief Operating Officer
2026-04-07
Cote Elissa S.
Chief Corp Development Officer
2026-04-07